Skip to search formSkip to main contentSkip to account menu

ONO 2235

Known as: ONO-2235 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

epalrestat

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
The role of sorbitol pathway and treatment effect of aldose reductase inhibitor ONO2235 in the up-regulation of cardiac M2-muscarinic receptors in streptozotocin-induced diabetic rats
1999
1999
Administration of an aldose reductase inhibitor, ONO-2235, to streptozotocin-diabetic mice restores reductions of DRG neuronal attachment to extracellular matrix proteins in vitro
1998
1998
Mitochondrial aldehyde reductase: identification and characterization in rat liver and kidney cortex.
1992
1992
Effect of aldose reductase inhibitor on the inhibition of platelet aggregation induced by diabetic rat plasma.
1992
1992
The role of cyclic adenosine 3',5'-monophosphate and polyol metabolism in diabetic neuropathy.
The effects of a stable prostacyclin analog, Iloprost, and aldose reductase inhibitors (ONO-2235 and isoliquiritigenin) were… 
1991
1991
Polyol pathway in tissues of spontaneously diabetic Chinese hamsters (Cricetulus griseus) and the effect of an aldose reductase inhibitor, ONO-2235.
1991
1991
Effect of glucose and an aldose reductase inhibitor on myo-inositol uptake by cultured human endothelial cells.
The effects of an aldose reductase (AR) inhibitor, elevated glucose and other compounds were evaluated on in vitro 2-[3H] myo… 
1988
1988
Effects of anti-inflammatory drugs and ONO-2235 on lens aldose reductase and on sorbitol accumulation in red blood cells
1987
1987
Photo-stabilization and solubilization of an aldose reductase inhibitor, (E)-3-carboxymethyl-5-[(2E)-methyl-3-phenylpropenylidene]rhodani ne (ONO-2235), by human serum albumin.
Photo-stabilization and solubilization of an aldose reductase inhibitor, (E) -3-carboxymethyl-5- [(2E) -methyl-3… 
1985
1985
Effects of a fructose-rich diet and the aldose reductase inhibitor, ONO-2235, on the development of diabetic neuropathy in streptozotocin-treated rats
SummaryStreptozotocin-diabetic rats were maintained on a 72% fructose diet for 4 weeks and some were treated with an aldose… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)